SCHEMBL19857513

SCHEMBL19857513

CSc1ncc(CO)c(N[C@@H]2CCC(O)C2C)n1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.41
▸ MERTK Q12866 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863583 1.00 HTT (0.41) HTTMERTK
SCHEMBL19857443 1.00 HTT (0.41) HTTMERTK
SCHEMBL19857309 1.00 HTT (0.41) HTTMERTK
SCHEMBL19863584 1.00 HTT (0.41) HTTMERTK
SCHEMBL19863585 1.00 HTT (0.41) HTTMERTK
SCHEMBL29593581 1.00 HTT (0.41) HTTMERTK
SCHEMBL19863586 0.93 HTT (0.40) HTTMERTK
SCHEMBL20801453 0.93 HTT (0.40) HTTMERTK
SCHEMBL24669666 0.84 HTT (0.42) HTTMERTK
SCHEMBL28294289 0.81 HTT (0.42) HTTMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10233188-B2 CDK2/4/6 inhibitors PFIZER INC. (US) 2019-03-19 — — US disclosed
US-20180044344-A1 CDK2/4/6 Inhibitors PFIZER INC. (US) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044344-A1 CDK2/4/6 Inhibitors CDK2, CDK6, CDK20 HTT 3428/4885MERTK 3203/4885
US-10233188-B2 CDK2/4/6 inhibitors CDK2, CDK6, CDK20 HTT 3428/4885MERTK 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback